Zoetis Inc. Stock Underperforms Monday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Zoetis Inc. (ZTS) shares fell 1.11% to $72.97 on Monday, underperforming competitors like Merck & Co. and IDEXX Laboratories during a broader market decline. This marks the second consecutive day of losses for Zoetis, which is currently trading 54.53% below its 52-week high of $160.48 reached in August. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Zoetis Inc. (ZTS) slipped 1.11% to $72.97 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,745.06 and Dow Jones Industrial Average falling 0.51% to 53,459.78.
This was the stock's second consecutive day of losses.
Zoetis Inc. closed 54.53% below its 52-week high of $160.48, which the company reached on August 20th.
The stock underperformed when compared to some of its competitors Monday, as Merck & Co. Inc. (MRK) rose 0.10% to $135.97 and IDEXX Laboratories Inc. (IDXX) fell 0.88% to $546.09.
Trading volume (6.6 M) remained 293,577 below its 50-day average volume of 6.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-17-26 1659ET